• R&D




Medical Device Hydrogels

Carboxymethyl Cellulose Platform

New medical devices based on Carboxymethylcellulose Crosslinkata for tissue augmentation, constitute today one absolute innovation on the world market. The potential benefits in terms of costs, production, performance and development, will bring Crosslinkata to carboxymethyl cellulose compete with other medical absorbable devices on the market. Carboxymethyl cellulose, could become the new starting point for the development of new devices used in other applications for medical use.

Hyaluronic Acid Platform

Hyaluronic acid is currently the gold standard in the context of implantable medical devices, which are used in specialized areas of medicine. Bioitech is developing a procedure for the use of hyaluronic acid crosslinkato in ophthalmological and aesthetic context.
Research for the Future focuses on physiological preparations that slow down the degradation of hyaluronic acid by hyaluronidase, with the addition of polymer retarders.
Finally, some studies are focused on finding those chemical changes that can amplify Rheological characteristics that have decreed in the success of hyaluronic acid.

Medical Device Components

Plunger Rods

Started the production of Plunger Rod for syringes used for dermal filler with the purpose of improving handling of Erelle ™.

Raw Materials


In the final phase the study which allowed pulverize crosslinked hyaluronic acid with cross-linking degrees overlapping with those used for filler for aesthetic use.



Key Business Areas

Carboxymethyl Cellulose Platform


Hyaluronic Acid Platform

Syringe Components


© 2012, BIOITECH S.r.l. All right reserved | C.F. e P.I. 10671701000 | Via Chiana, 87 00198 - Roma (Italy)

Site Map | Legal